Education
About Us
Working with TipRanks
Follow Us
Pro-Dex (DE:PDXN)
FRANKFURT:PDXN
PDXN Stock Chart & Stats
Day’s Range― - ―
52-Week Range€15.20 - €61.50
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$185.52M
Enterprise Value€169.09M
Total Cash (Recent Filing)$3.35M
Total Debt (Recent Filing)$3.00M
Price to Earnings (P/E)―
Beta-0.46
Next Earnings
May 01, 2025EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,261,043
10 Day Avg. Volume1
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.62
Price to Cash Flow (P/CF)-9.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.91
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.62
Enterprise Value/Ebitda14.05
Forecast
1Y Price Target
$47.34Price Target Upside-9.82% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Pro-Dex News
PremiumCompany Announcements
Pro-Dex, Inc. Reports Strong Q2 Growth in 2025
PremiumCompany Announcements
Pro-Dex Grants Restricted Shares to Key Executives
PremiumCompany Announcements
Pro-Dex, Inc. Reports Strong Quarterly Earnings Growth
PremiumPre-Earnings
Is PDEX a Buy, Before Earnings?
PremiumCompany Announcements
Pro-Dex Executives Awarded Bonuses for Strong Fiscal Performance
---
Bulls Say, Bears Say
Bulls Say
Analyst ConfidenceAnalyst maintains a BUY rating and raises the 12-month price target to $52, reflecting confidence in the company’s strong growth potential.
Product DiversificationPro-Dex is diversifying its customer base and product lines by developing new devices, which is seen as a positive move.
Revenue GrowthPro-Dex reported fiscal Q2 2025 revenue of $16.8 million, a 33% increase year-over-year, exceeding estimates.
Bears Say
Market DemandPro-Dex is focusing on highly specialized medical and dental devices, creating a proprietary niche in contract manufacturing with substantial market demand.
Operational ChangesA new manufacturing facility and completed transfer of operations are expected to provide adequate facilities for strong future growth.
---
Options Prices
Currently, No data available
---
Ownership Overview
44.74% Insiders
6.37%
Mutual Funds
6.78% Other Institutional Investors
37.21% Public Companies and
Individual Investors
PDXN FAQ
What was Pro-Dex’s price range in the past 12 months?
Pro-Dex lowest stock price was €15.20 and its highest was €61.50 in the past 12 months.
What is Pro-Dex’s market cap?
Pro-Dex’s market cap is $185.52M.
When is Pro-Dex’s upcoming earnings report date?
Pro-Dex’s upcoming earnings report date is May 01, 2025 which is in 5 days.
How were Pro-Dex’s earnings last quarter?
Pro-Dex released its earnings results on Jan 30, 2025. The company reported €0.535 earnings per share for the quarter, beating the consensus estimate of €0.333 by €0.202.
Is Pro-Dex overvalued?
According to Wall Street analysts Pro-Dex’s price is currently Overvalued.
Does Pro-Dex pay dividends?
Pro-Dex does not currently pay dividends.
What is Pro-Dex’s EPS estimate?
Pro-Dex’s EPS estimate is 0.41.
How many shares outstanding does Pro-Dex have?
Pro-Dex has 3,261,043 shares outstanding.
What happened to Pro-Dex’s price movement after its last earnings report?
Pro-Dex reported an EPS of €0.535 in its last earnings report, beating expectations of €0.333. Following the earnings report the stock price went down -1.942%.
Which hedge fund is a major shareholder of Pro-Dex?
Currently, no hedge funds are holding shares in DE:PDXN
---
Pro-Dex Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$47.34 (-9.82% Downside)
$47.34 (-9.82% Downside)
Insider Transactions
Sold Shares
Worth $40.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
251.51%
12-Months-Change
Fundamentals
Return on Equity
21.22%
Trailing 12-Months
Asset Growth
17.40%
Trailing 12-Months
Company Description
Pro-Dex
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
---
PDXN Stock 12 Month Forecast
Average Price Target
€47.34
▼(-9.82% Downside)
Technical Analysis
InfuSystem Holdings, Inc.
―
Orasure Technologies
―
Stereotaxis
―
Utah Medical Products
―
Sanara MedTech
―
Best Analysts Covering PDXN
1 Year
1 Year Success Rate
11/18 ratings generated profit
1 Year Average Return
+42.83%
reiterated a buy rating 2 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +42.83% per trade.
---